Erlonat-Erlotinib Erlonat belongs to a class of medications called Kinase inhibitors and contains erlotinib. It is used for the treatment of non-small cell lung cancer and in combination with Gemcitabine, is used for the treatment of pancreatic cancer which spreads to adjacent tissues of the body. The action mechanism of the medicine is as follows: Functions by blocking the action of an abnormal protein to slow down the growth of cancer cells Supplied as: Available in 25 mg, 100 mg & 150 mg tablets
in section "Pharmaceutical Ointments"
View also products categories "Ointments"